Table 3 Univariate and multivariate analysis of the study variables in men

Age grouped

389,030

 41—50

134,104 (34.5%)

1

–

1

–

 51—60

97,416 (25%)

4.4

(4.1—4.8)

3.4

(3.1—3.7)

 61—70

76,965 (19.8%)

13.2

(12.2—14.3)

8.7

(8—9.4)

 71—80

51,763 (13.3%)

27.1

(25.1—29.3)

18.8

(17.3—20.5)

 80 or more

28,782 (7.4%)

34.2

(31.5—37.1)

29.1

(26.6—31.8)

Smoking

389,030

173,001 (44.5%)

4.1

(4—4.3)

3.5

(3.4—3.6)

Bronchiectasis

389,030

10,479 (2.7%)

31.3

(30—32.7)

20.5

(19.5—21.6)

Cor Pulmonale

389,030

451 (0.1%)

21.0

(17.4—25.2)

5.3

(4.3—6.7)

Lung Cancer

389,030

1790 (0.5%)

8.2

(7.4—9.1)

3.6

(3.2—4)

Heart Failure

389,030

7155 (1.8%)

7.9

(7.4—8.3)

2.4

(2.3—2.6)

OSAS

389,030

8767 (2.3%)

2.9

(2.7—3.1)

1.7

(1.6—1.9)

Osteopathy

389,030

3228 (0.8%)

4.4

(4.1—4.9)

1.6

(1.5—1.8)

Alcohol Consumption Risk Rate

389,030

 No intake

94,120 (24.2%)

1

1

 Low

80,222 (20.6%)

0.9

(0.9—0.9)

0.9

(0.9—1)

 Moderate or High

7855 (2%)

1.1

(1—1.2)

1.3

(1.1—1.4)

 NA

206,833 (53.2%)

0.3

(0.3—0.3)

0.7

(0.7—0.8)

Depression

389,030

30,568 (7.9%)

1.4

(1.4—1.5)

1.3

(1.2—1.3)

Ischaemic Cardiomyopathy

389,030

14,546 (3.7%)

3.1

(2.9—3.3)

1.2

(1.1—1.3)

AF

389,030

13,974 (3.6%)

4.1

(3.9—4.3)

1.2

(1.1—1.3)

Anaemia

389,030

17,209 (4.4%)

3.3

(3.2—3.5)

1.2

(1.1—1.2)

Chronic kidney failure

389,030

16,268 (4.2%)

3.5

(3.3—3.6)

1.1

(1—1.2)

Dyslipidaemia

389,030

122,087 (31.4%)

1.9

(1.8—1.9)

1.0

(0.9—1)

Hypertension

389,030

131,174 (33.7%)

2.9

(2.8—3)

0.9

(0.9—1)

DM2

389,030

58,219 (15%)

2.3

(2.3—2.4)

0.9

(0.9—1)

Grouped BMI

389,030

 Normal

25,352 (6.5%)

1

–

1

–

 Overweight

67,457 (17.3%)

0.8

(0.7—0.8)

0.8

(0.7—0.8)

 Obesity

47,140 (12.1%)

0.9

(0.8—0.9)

0.9

(0.8—0.9)

 NA

249,081 (64%)

0.2

(0.2—0.2)

0.7

(0.7—0.8)

ROC Curve

0.896 (0.89—0.9)